Skip to content

Pediatric Early Rehabilitation in Acute Lymphoblastic Leukemia

Pediatric Early Rehabilitation in ACute Lymphoblastic LEukemia (PEACE): A Feasibility Study of a Hybrid Delivery Format

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06170385
Acronym
PEACE
Enrollment
10
Registered
2023-12-14
Start date
2024-04-15
Completion date
2025-12-31
Last updated
2026-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neoplasms, Pediatric Cancer, Physical Therapy, Telemedicine

Brief summary

The purpose of this study is to determine the feasibility and acceptability of a hybrid in-person and virtual individualized physiotherapy program using the Healthy Eating and Active Living (HEAL-ME) online platform for children diagnosed with acute lymphoblastic leukemia. We would like to know if this type of hybrid program delivery model is feasible, and if children and their parents are willing and able to participate in the program. We will do this by recording how many, and what type of physiotherapy sessions (in-person or virtual) are completed, what resources offered on the platform are accessed, and how many children complete the assessments.

Detailed description

Acute lymphoblastic leukemia is the most common childhood cancer, representing approximately 25% of cancers in children. Improvements in survival rates have resulted in an increased number of children living with neuromuscular and musculoskeletal side effects of cancer treatments-effects that may persist or worsen over the long-term into adulthood. The overall goal of the study is to determine the feasibility of a tailored physiotherapy (PT) program using an online platform for children diagnosed with acute lymphoblastic leukemia. A quasi-experimental, single group, before and after intervention feasibility study will be conducted, comprising a convenience sample of a minimum of 10 children between 4 and 17 years of age undergoing or having completed chemotherapy treatment for acute lymphoblastic leukemia. Children will participate in a hybrid 12-week PT program delivered in-person at the Stollery Children's Hospital with educational components provided virtually via the Healthy Eating and Active Living web-based platform. Children will participate in six physical therapy sessions over a period of three months and will have the option to choose the mode of delivery: 1:1 in-person, 1:1 virtual, group virtual, or combination of all. The main outcome will be feasibility, as determined by recruitment and retention rates, completion rates of measurements, adherence to sessions, and safety and acceptability.

Interventions

BEHAVIORALPhysical Therapy

Each physical therapy session will commence with a 5-minute warm-up, with fun activities to mobilize the joints and activate the muscles, using the videos available in the HEAL-ME platform. The warm-up session will be followed by a 20 to 40-min program with tailored activities and games comprising jumping, squatting, skipping, balancing, and jogging. The session will finish with a 5-minute cool down with stretching exercises and a relaxation video from the HEAL-ME platform.

Sponsors

University of Alberta
Lead SponsorOTHER
Alberta Health services
CollaboratorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

Quasi-experimental single group before and after study

Eligibility

Sex/Gender
ALL
Age
4 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

1. Children diagnosed with acute lymphoblastic leukemia aged between 4 and 17 years (at time of diagnosis) and their mother, father, or primary carer; 2. Undergoing or completed cancer treatment as established by the Children's Oncology Group; 3. Access to the internet through a home computer or tablet; 4. Patient or caregiver is able to speak and comprehend English; and 5. The child is approved by their Oncologist to participate in the program.

Exclusion criteria

1. Children with a history of a neurodevelopmental or genetic disorder (i.e., Down syndrome, autism, seizure disorder) prior to the cancer diagnosis; and 2. Children with a concurrent condition (illness, disease, psychiatric disorder), as determined by oncologist or physiotherapist, that would compromise study participation or interpretation of study results.

Design outcomes

Primary

MeasureTime frameDescription
Retention ratePost-intervention: 12 weeksThe number of participants completing the intervention and assessments

Secondary

MeasureTime frameDescription
Recruitment rateOne yearNumber eligible divided by the number of participants enrolling in the study
Adherence to study interventionPost-intervention: 12 weeksAttendance rates for in-person and virtual physical therapy sessions
Adverse eventsOne yearNumber of serious and non-serious adverse events
AcceptabilityPost-intervention: 12 weeksSatisfaction survey
Health-related Quality of LifePost-intervention: 12 weeksPediatric Quality of Life Inventory Version 4: Total scale score, with higher scores reflecting better quality of life

Countries

Canada

Contacts

PRINCIPAL_INVESTIGATORMargaret McNeely, PhD

University of Alberta

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 7, 2026